ABSTRACT Necrotic enteritis is a disease caused by Clostridium perfringens, which threatens poultry production in the absence of dietary antibiotics. A total number of 600 Ross broilers were reared in 12 pens with each hosting 50 birds. Each 6 pens of birds were fed medicated (bacitracin at 55 mg/kg) or nonmedicated starter diets immediately after the chicks were placed. At d 18, birds were challenged with C. perfringens (10 7 cfu/mL mixed with feed). Spleens were collected from 12 birds of each group (2 birds per pen randomly) at d 18 (before infection), 19, 20, and 22. A low-density chicken immune microarray was used to study gene expression profiling of host response to C. perfringens infection. Six biological replicates (2 birds per biological replicate) for each treatment group were labeled with either Cy5 or Cy3 with dye swap. A total of 24 arrays were used for this study. Gene signal intensity was globally normalized by locally weighted regression and smoothing scatter plots and expressed on a natural log scale. A mixed model including treatment, time, array, subgrid (random effect), dye, and all interactions among treatment and time was used to identify differentially expressed genes between postinfection vs. preinfection, among postinfections, and between medication treatments, at the 5% significance level. The results indicated subtle medication effects on gene expression of these immune-related genes compared with bacterial infection effect. Our findings strongly suggest that both cell-mediated and antibody-mediated immune responses via MHC class I and II systems were actively involved in the host defense against C. perfringens infection in broilers. The unique cytokine signaling pathway and apoptosis cascade found in the study provide a new insight of molecular regulation of host immune response. Collectively, the findings of the present study will shed light on the molecular mechanisms underlying C. perfringens infection in broilers.
INTRODUCTION
Clostridium perfringens is a gram-positive, anaerobic, and spore-forming bacterium. It can be found in the intestinal tract of chickens (Al-Sheikhly and Truscott, 1977a,b) and humans (Egert et al., 2007) . The overgrowth of C. perfringens in the small intestine can result in necrotic enteritis (NE), an enteric disease that can cause a significant economic loss in the poultry industry (Olkowski et al., 2008) . On the other hand, consuming poorly prepared poultry meat contaminated with this bacterium can cause food poisoning, the third most common cause of foodborne illness in the world (Warrell, 2003) . The typical clinical sign of this infection in humans includes abdominal cramping and diarrhea (Bos et al., 2005) . Therefore, C. perfringens is not only a threat to commercial poultry production but also a concern in preharvest food safety (Van Immerseel et al., 2004) .
The use of dietary antibiotics has been one of the primary measures to control NE in poultry production (Prescott et al., 1978; George et al., 1982; Stutz and Lawton, 1984; Collier et al., 2003) . However, there has been a great concern over the potential that antibioticresistant bacteria can be transferred to humans, thus reducing the therapeutic efficacy of antibiotics used to treat bacterial infections in humans (DuPont, 2007) . With the pressure from the general public, the removal of dietary antibiotics as growth promoters in poultry production has been enforced in European Union countries and is under review in Canada. The restricted use of dietary antibiotics for food animals in the European Union has led to the prevalence of NE in poultry production (McDevitt et al., 2006) . There is an urgent need to elucidate molecular mechanisms underlying the pathogenesis of NE and effect of antibiotics on NE in chickens, to control NE prevalence.
Transcriptional profiling of host response to C. perfringens infection in chickens will provide more insight of NE pathogenesis. There have been no reports, to our best knowledge, on the gene expression profiling of host response to C. perfringens infection in the chicken. The objective of the current study was to reveal molecular mechanisms underlying C. perfringens infection at different time points postinfection and gene expression profiling between nonmedicated and medicated birds using a chicken immune system microarray.
MATERIALS AND METHODS

Experimental Birds
The chickens used in the present study were the same birds for a previously published paper studying expression of α-toxin in chicken guts (Si et al., 2007) . Briefly, a total number of 600 Ross broilers were reared in 12 pens with each hosting 50 birds. Each 6 pens of birds were fed a medicated (bacitracin at 55 mg/kg) or a nonmedicated typical all-vegetable starter diet (ShurGain, Nutreco Canada) immediately after the chicks were placed. At d 18, birds were challenged with a type A C. perfringens isolate (Brennan et al., 2001) 
Microarray Experiment Design
For the microarray study, 2 birds from each pen were pooled within each group. To account for any bias inherent to the fluorescent dyes, 3 of the 6 medicated replicates were labeled with Cy3 and the other 3 were labeled with Cy5 at each time point. The same design was applied for the nonmedicated group. There were 6 hybridizations between medicated and nonmedicated replicates at each time point. Twenty-three out of 24 arrays were used (data from 1 array were discarded due to poor quality).
The chicken immune system low-density array used for hybridization in these studies was an extended version of the array described previously (Sarson et al., 2007) . The array has been submitted to the National Center for Biotechnology Information Gene Expression Omnibus database under the accession number GPL4585.
Array Hybridizations
Total RNA was extracted from spleens using Trizol reagent (Invitrogen, Burlington, Ontario, Canada) according to the recommendations of the manufacturer. Total RNA was then treated with DNase using the DNAfree Kit (Ambion, Austin, TX) and 5 μg was transcribed into cDNA using 100 ng of random hexamers and SuperScript II Reverse Transcriptase (Invitrogen) using a 2:3 ratio of 5-(3-aminoallyl)-deoxyuridine triphosphate (Ambion) to unlabeled deoxythymidine triphosphate [0.5 mM deoxyadenosine triphosphate, 0.5 mM deoxycytidine triphosphate, 0.5 mM deoxyguanosine triphosphate, 0.3 mM deoxythymidine triphosphate, and 0.2 mM 5-(3-aminoallyl)-deoxyuridine triphosphate] for 2 h at 42°C. After reverse transcription, 6 μL of 0.5 M EDTA and 6 μL of 1 N NaOH were added. The mixture was incubated at 65°C for 15 min and then neutralized with 16 μL of 1 M Tris (pH 7.4). The samples were concentrated into approximately 5 μL with Microcon YM-30 filters (Millipore, Mississauga, Ontario, Canada) and the cDNA was then labeled with the Cy3 and Cy5 monofunctional dyes (GE Healthcare Bio-Sciences, Baie d'Urfe, Quebec, Canada). The unincorporated dye was removed with the QIA-Quick PCR Purification Kit (Qiagen, Mississauga, Ontario, Canada) and the labeled cDNA samples were dried in a speed-vac. The pellet was dissolved in 12 μL of salt-based hybridization buffer (Ocimum Biosolutions, Indianapolis, IN) and 1 μL of salmon sperm DNA. The labeled samples were then heated at 95°C for 5 min and cooled to room temperature before hybridization.
The labeled probes were hybridized to the microarrays for 16 h at 65°C. After hybridization, the slides were washed and images acquired using a ScanArray Express instrument and analyzed with the ScanArray Express software, version 3.0 (PerkinElmer, Montreal, Quebec, Canada). For each gene, there were 6 technical replicates spots on the array. The average of 6 spots was used for each gene. Mean signal intensity and median background intensity were normalized using locally weighted regression and smoothing scatter plots within slide and centering and scaling were applied to normalize the data between slides. A mixed model including the effects of treatment, time point, dye, replicate, slide, and interactions between treatment and time point was used to identify differentially expressed genes. The estimate function from SAS was used to compare between medicated vs. nonmedicated groups and between different time points. The criteria for differential expression were established to include statistical significance reported at P < 0.05, a signal:noise ratio ≥2, and a fold change of intensity >1.2. The false discovery rate (Q value) was calculated for each P-value using the R program according to the Storey and Tibshirani (2003) method.
The total of 23 microarray data have been submitted to the National Center for Biotechnology Information Gene Expression Omnibus database under the series accession number GSE13085 and series sample identification numbers GSM327415, GSM327416, GSM327418, and GSM327670 to GSM327689.
Real-Time PCR
Subsets of genes (P < 0.05) showing differential expression between the medicated and nonmedicated groups during microarray analysis were selected for validation by real-time PCR. Primers for these selected genes are presented in Table 1 . The cDNA synthesis on 4 replicates was performed with 1 μg of total RNA using 100 ng of random hexamers and SuperScript II Reverse Transcriptase (Invitrogen) according to the recommendations of the manufacturer. Expression levels were normalized to β-actin gene expression, which was used as an internal housekeeping control. Real-time quantification was performed in the LightCycler Instrument (Roche Diagnostics, Laval, Quebec, Canada) using the SYBR Green dye. The PCR mixtures (final volume of 20 μL) contained 2 μL of the LightCycler FastStart DNA Master SYBR Green I (Roche Diagnostics), 2 μL of a 1:100 dilution of the cDNA, 3 μM MgCl 2 , and 0.5 mM of each primer. The cycling conditions included an initial heat-denaturing step at 95°C for 10 min, 40 cycles at 95°C for 10 s, annealing as described in Table  1 for each of the primers, and product elongation and signal acquisition (single mode) at 72°C for 10 s. After amplification, the melting curves were determined in a 3-segment cycle of 95°C for 0 s, 65°C for 15 s, and 95°C for 0 s at the continuous acquisition mode. The temperature transition rates were set at 20°C/s except for segment 3 of the melting curve analysis, where it was set to 0.1°C/s.
The quantitative real-time PCR data were analyzed using the 2 −ΔΔCt method of (Livak and Schmittgen, 2001 ). Briefly, the relative level of each mRNA normalized to the β-actin gene was calculated using the following
. The Student's t-test was used to compare gene expression between the medicated group vs. nonmedicated group. A P-value of less than 5% was considered statistically significant.
RESULTS
Antibiotic Effect on Gene Expression in Spleen
Differentially expressed genes between the bacitracinmedicated and nonmedicated group at each time point were identified (P < 0.05). There were 13, 9, 21, and 9% genes significantly differentially expressed at d 0 PI (before C. perfringens infection), d 1 PI, d 2 PI, and d 4 PI, respectively ( Table 2 ). The Q values range from 12 to 41% at the 5% of P-values. 
Temporal Gene Expression Changes in Spleen of Bacitracin-Medicated Group
Gene Regulation During the Time Course of C. perfringens Infection
The fold changes of significantly differentially expressed genes (P < 0.05) from each comparison are shown in Table 3 . There were 28 genes, which were upregulated by infection in the comparisons of postinfection vs. d 0 PI but downregulated by time in the comparisons among postinfection groups in both medicated and nonmedicated groups. More than half of these genes showed ≥2-fold changes in the comparisons of postinfection vs. preinfection, whereas in cases of genes that were repressed in the comparisons among postinfection groups, those changes were less than 2-fold. Among these genes were MHC class I or II related genes, transcription and signal transduction, and surface molecules. The MHC class I or II related genes included B-F, β2-microglobulin (B2m), calreticulin, calnexin, B-Lb, invariant chain, as well as other important immune system genes, such as CD45, IL 2 α receptor, IgA, and IgG. Transcription and signal transduc- tion genes were Bu-1, growth factor receptor-binding protein 2, B-cell adaptor containing SH2 domain, signal transducer and activator of transcription (STAT)-2, and STAT-4. Surface molecules were CD18, CD44, CD63, CD82, and CD164, and in general, they can express on T cells and B cells. However, the directions of regulation were opposite in another 29 genes, which were downregulated in the comparisons of postinfection vs. d 0 PI but upregulated in the comparisons among postinfection groups. Among these genes were cytokines, chemokines, their receptors, and apoptosisrelated genes. Nearly all significantly expressed genes exceeded 2-fold changes whether they were upregulated in the comparisons of postinfection vs. d 0 PI or they were downregulated in the comparisons among postinfection groups. Cytokines, chemokines, and their receptors were IL-1β, IL-2, IL-16, IL-18, interferon-γ (IFNg) , TRAF6, C-maf, osteoprotegerin, IL-8, macrophage inflammatory protein 1 β, CXCR1, chemokine (C-C motif) receptor 8, AH294, and TCA. Apoptosis-related genes were caspase 8, caspase 9, FLIP, Fas, granzyme A, and apoptosis-associated protein.
Validation of Microarray Results by Real-Time PCR
Genes that were differentially expressed in multiple incidences at different time points were selected for validation using real-time reverse transcription-PCR. These genes included CD8α, caspase 3, B2m, STAT-2, IgG, MHC II (B-Lb), and CD107. Expression levels were normalized to β-actin expression, which was used as an internal housekeeping control. Overall, there was 84% agreement between real-time PCR and microarray gene expression data (Table 4) .
DISCUSSION
The promise of gene expression profiling using microarray technology has created a new avenue for elucidation of molecular mechanisms of disease processes in animals. It also offers a systematic means to generate a wealth of data needed to enhance our understanding of bacterial infection in animals. The immune system microarray used in the present study provided an opportunity to interrogate changes of gene expression in these annotated immune-related genes simultaneously after C. perfringens infection in broilers.
Gene Expression Differences Between Medicated and Nonmedicated Groups
In this study, we investigated systemic host responses to C. perfringens infection in broilers by measuring mRNA of immune system genes in spleen. In our previous report, bacitracin was shown to be effective in controlling C. perfringens and its α-toxin production, and NE lesions in the small intestine of broilers (Si et al., 2007) , due to its activity against gram-positive cocci and bacilli through the action of inhibition toward lipid pyrophosphorylase for the synthesis of peptidoglycan. There were few C. perfringens cells and no α-toxin mRNA detected in the ileal digesta, and no NE lesions in the ileum of the medicated birds. Therefore, it was expected that many immune system-related genes would be differentially regulated between medicated vs. nonmedicated chickens because there was a large number of C. perfringens cells interacting with the host immune system at intestinal mucosa of the nonmedicated birds, whereas there was negligible C. perfringens found in the intestine of the medicated birds. Interestingly, the number of differentially expressed genes between medicated and nonmedicated groups was much fewer than that in the comparison of postinfection vs. preinfection. There might be 2 reasons accounting for this observation: 1) many genes regulated by medication might have subtle changes in mRNA transcripts, which was unable to be detected as significant changes in the microarray analysis and 2) the small intestine is a major site for interactions between the host and C. perfringens; hence, if no systemic immune response is elicited, the response within the spleen might be trivial in this case. Therefore, transcription profiling of ileum gene expression is expected to provide more information on host response to this organism. Indeed this is an ongoing work at our laboratory. In addition, the results also indicated that the number of differentially expressed genes at different days of postinfection was associated with progression of NE lesions and the number of C. perfringens cells in the ileal digesta in nonmedicated birds (Si et al., 2007) . On d 2 PI, NE lesions were most serious (the highest number of differentially expressed genes) and then started to decline on d 4 PI (Si et al., 2007) . This pattern might serve as an indicator of pathogenesis of C. perfringens infection in broilers.
Gene Expression Changes During Pathogenesis of C. perfringens Infection in Broilers
Gene expression changes can reflect cellular and molecular biological process during host response to C. perfringens infection in broilers. Therefore, the number of differentially expressed genes between postinfection and preinfection and between different time points of postinfection in both nonmedicated and medicated groups was analyzed (Figures 1 and 2) . Compared with the nonmedicated group, the number of differentially expressed genes on d 4 PI vs. d 0 PI (postinfection vs. preinfection) decreased for the medicated group, although on both d 2 PI vs. d 1 PI and d 4 PI vs. d 1 PI (between postinfection), the number of genes increased for the same group. These results were not beyond our expectation because bacitracin given to the medicated group significantly reduced the burden of C. perfringens in the small intestine, thereby decreased stimuli to the host, and subsequently fewer genes were differentially regulated.
After C. perfringens infection in the present study, B-F, B2m, calnexin, calreticulin, TAP2, and CD8β were significantly upregulated (Table 3) . It has been found that B2m, B-F, calnexin, calreticulin, and transporters associated with antigen processing are essential molecules for MHC class I assembly as well as processing and presentation of antigens to CD8 T cells (Zhang and Williams, 2006) . These findings indicated that MHC class I molecules and cytotoxic T cells may be involved in the host immune response against C. perfringens. In addition to genes encoding various molecules of MHC class I antigen processing and presentation pathways, genes encoding MHC class II or their associated molecules, namely B-Lb and invariant chain, were highly upregulated after C. perfringens infection. This raises the possibility of involvement of MHC class II and T cells restricted to these molecules in response to this bacterium. Indeed, we discovered that an adhesion molecule, lymphocyte function-associated antigen-1, which has an important role in formation of the immunological synapse, is upregulated. Moreover, CD45, which is an important signaling molecule for lymphocytes, was also highly upregulated. Activation of T cells may provide help for B cells, leading to their differentiation and elicitation of antibody production. This was confirmed by our observation of an upregulation in expression of IgA and IgG genes. In summary, with the infection of C. perfringens in broilers, both T cells and B cells in spleen may be activated to induce an immune response against the pathogen.
Several genes encoding important molecules involved in the process of apoptosis were highly downregulated after infection. Apoptosis or programmed cell death is an essential biological process for maintenance of homeostasis in various tissues and organs, including the immune system. Several key genes involved in the apoptosis pathway have been studied in the present study including caspase 8, 9, Fas, FLIP, granzyme A, and apoptosis-associated protein. Several apoptosis pathways can be induced by these different ligands. It has been found that Fas and granzyme A are 2 ligands that can initiate the apoptosis pathway (Xu and Shi, 2007) , whereas FLIP is a important gene expression regulator of the apoptosis pathway (Ekert et al., 1999; Harada and Grant, 2003) . Caspases are a class of cysteine proteases that are involved in apoptosis and can send the apoptotic signal in a proteolytic cascade that initiates and activates the apoptosis process. Specifically, caspase 8 and 9 are 2 proteins that are active in the initiation of the cascade followed by Fas, granzyme, and FLIP activation (Yang et al., 1997; Matsuno et al., 2003) . Interestingly, all of the genes described above were downregulated after C. perfringens infection, which indicated an inhibition of apoptosis process in chicken spleen at the early stage of C. perfringens infection. Because C. perfringens infection causes local inflammatory response in the small intestine, activation of apoptosis in the gastrointestal tract is expected. However, spleen is a secondary lymph organ for systemic immune response. The inhibition of apoptosis in spleen might be needed for maintaining a sufficient numbers of cells for inducing and maintaining immune activity. In fact, in other animals, prevention of apoptosis is usually associated with enhanced immune response, which may even sometimes leads to autoaggressive responses (Krammer, 2000; Krammer et al., 2007) . Further investigation of this pathway in an apoptosis-specific experiment is warranted to delineate this regulatory mechanism.
All differentially regulated cytokines, chemokines, and their receptors were downregulated after C. perfringens infection in the present study. These genes included IL-2, IL-8, IL-16, IL-18, IL-1 β, IFN-g, CXCR1, chemokine (C-C motif) receptor 8, macrophage inflammatory protein 1 β, and AH294. Cytokines and chemokines and their receptors play essential roles in the regulation of host immune response. Many studies have revealed these genes to be significantly modulated during bacterial infection in animals, including chickens (Swaggerty et al., 2004 (Swaggerty et al., , 2006 Withanage et al., 2005; Wigley et al., 2006; Park et al., 2008) . A recent gene expression study after C. perfringens infection in broilers indicated that IL-2, IL-1 β, IFN-g, and IL-16 were upregulated in intestinal epithelial cells on d 1 and 2 after C. perfringens infection except a decrease at d 1 and increase at d 1 PI for IL-8 (Park et al., 2008) . In other studies, Salmonella infection in chickens was also shown to increase IL-1 β, IFN-g, and IL-18 splenic mRNA expression (Cheeseman et al., 2007) , as well as IL-8 and IL-18 expression in heterophils (Swaggerty et al., 2006) . It should be noted that broilers were challenged with C. perfringens only in the present study, which differed from the report by Park et al. (2008) , in which chickens were infected with a combination of Eimeria maxima and C. perfringens. In addition, intestinal epithelial cells rather than spleens were examined for the expression of cytokine genes. Whether these differences account for the different observations in the 2 studies for cytokine gene expression remains to be determined. It appeared that cytokines and chemokines were downregulated during the first 2 d postinfection and then upregulated at d 4 PI. We speculate that there might not be sufficient stimulation for induction of immune response in spleen during the early stage of infection due to the nature of local infection of C. perfringens in the intestine. During this stage of infection, cells that are stimulated and activated locally in the intestine may circulate in the body and enter the spleen. In fact, C. perfringens has been detected in the spleen of infected chickens (Collier et al., 2008) . Our preliminary data obtained recently also support this observation (our unpublished data). This is perhaps one of the explanations for our observation that genes associated with cell activation, such as those encoding MHC class I and II antigen processing and presentation as well as antibodies, CD45, CD8, and lymphocyte function-associated antigen-1, were upregulated. However, gradually, spleen may become a site for elicitation of immune response, which in our study was characterized by upregulation in expression of some of the cytokines and chemokines and their receptors during the late stages of infection.
In summary, very little is known about cytokine signaling pathway, antigen processing and presentation, and apoptosis pathway during pathogenesis of bacterial infection in chicken spleen. This is the first report, to our knowledge, using microarray technology to profile expression of immune-related genes during C. perfringens infection in broilers. Our findings indicate that both cell-mediated and antibody-mediated immune responses via MHC class I and II systems were actively involved in the host defense against C. perfringens infection in broilers. The unique cytokine signaling pathway and apoptosis cascade found in the present study may point to a new direction to study molecular regulation of host immune response. Taken together, the findings of the present study will shed light on the molecular mechanisms underlying C. perfringens infection in broilers.
